ArticleJournal of ophthalmology2020
Causes and Clinical Impact of Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy.
Article in Journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04018326 (Causes and Clinical Impact of Loss to Follow-up in Patients With Proliferative Diabetic Retinopathy), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Causes and Clinical Impact of Loss to Follow-up in Patients With Proliferative Diabetic Retinopathy
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis.Systematic reviews · 2023Pooled it
- Impact of Prior Diabetic Retinal Screening on Hospitalization and Ophthalmic Follow-Up in Diabetic Patients with Newly Diagnosed Proliferative Diabetic Retinopathy.Diagnostics (Basel, Switzerland) · 2026Article
- Identifying Patients at High Risk of Lapses in Diabetic Retinopathy Care: A Machine Learning Study.Ophthalmology science · 2026Article
- Interpreting Services Bridge Language Gaps in Diabetic Retinopathy Care: A Retrospective Cohort Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- The Association of Lapses in Diabetic Retinopathy Care with Vision Impairment.Ophthalmology science · 2026Article
- Quality of Care in Patients With Newly Diagnosed Glaucoma.JAMA ophthalmology · 2025Article
- Factors associated with lost to follow-up and delayed follow-up in patients with choroidal nevus.Eye (London, England) · 2025Article
- Determinants of lost-to-follow-up (LTFU) among National Health Insurance Scheme-insured hypertension and diabetes patients attending accredited health facilities in Ghana.Tropical medicine and health · 2025Article
- Measures of diabetic retinopathy treatment coverage: protocol for a methodological review.BMJ open · 2025Article
- Loss to Follow-Up in Patients With Proliferative Diabetic Retinopathy or Diabetic Macular Edema.JAMA network open · 2024Article
- Factors associated with the uptake and utilisation of diabetic retinopathy screening services in sub-Saharan Africa: A scoping review.PloS one · 2024Article
- Article
- Health Disparities in Lapses in Diabetic Retinopathy Care.Ophthalmology science · 2023Article
- Lost to follow-up of patients who received intravitreal anti-vascular endothelial growth factor therapy to treat four different retina disorders in an individual center in Brazil.SAGE open medicine · 2023Article
- Transition From Pediatric to Adult Nephrology Care: Program Report of a Single-Center Experience.Canadian journal of kidney health and disease · 2023Article
- Levels and Correlates of Numeracy Skills in Lebanese Adults with Diabetes: A Cross-Sectional Study.International journal of environmental research and public health · 2022Article
- Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022Article
- The Impact of Telemonitoring on Improving Glycemic and Metabolic Control in Previously Lost-to-Follow-Up Patients with Type 2 Diabetes Mellitus: A Single-Center Interventional Study in the United Arab Emirates.International journal of clinical practice · 2022Article
- A Paradigm Shift in the Management Approaches of Proliferative Diabetic Retinopathy: Role of Anti-VEGF Therapy.Clinical ophthalmology (Auckland, N.Z.) · 2022Review
- Urgent and emergent glaucoma care during the COVID-19 pandemic: An analysis at a tertiary care hospital in South India.Indian journal of ophthalmology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study determined the clinical impact and causes of loss to follow-up (LTFU) from the patients' perspective in individuals with proliferative diabetic retinopathy (PDR) who received panretinal photocoagulation (PRP) and/or intravitreal injections (IVIs) of antivascular endothelial growth factor (VEGF).
methodsThis prospective cohort study included 467 patients with PDR who received PRP and/or IVIs of anti-VEGF between May 2013 and June 2018. LTFU was defined as missing any follow-up visit for any interval exceeding 6 months, provided that patients eventually resumed care. Main outcome measures include rates and causes of LTFU.
resultsA total of 391 patients (83.7%) were followed up, and 76 patients (16.3%) were LTFU over the study period. Rates of LTFU decreased with age (
conclusionsLTFU threatens vision in PDR patients receiving PRP and/or IVIs of anti-VEGF. Possibly, patient-specific LTFU causes should be addressed before treatment in order to minimize the risk of LTFU. The clinical trial is registered with NCT04018326 (trial registration: ClinicalTrials.gov Identifier: NCT04018326, 10th of July 2019 "Retrospectively registered").
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.